🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yíngyún Caì

National Institutes of Health

ORCID: 0000-0002-1101-0920

Also affiliated with AstraZeneca (Netherlands), National Institute of Allergy and Infectious Diseases, AstraZeneca (Poland), AstraZeneca (United States)

MedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults”.

Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults

Clinical Infectious Diseases(2023)10.1093/cid/ciad693
N/A
0.671DataRank · unranked
16 citations

Ken Liu, Édouard Lhomme, Julie Blie, John McCullough, Matthew Onorato +90 more

Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases

Nature Communications(2024)10.1038/s41467-024-51453-z
N/A
0.596DataRank · unranked
19 citations

Édouard Lhomme, Mélanie Huchon, Emile Foucat, Marion Bérerd-Camara, Lydia Guillaumat +94 more

Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial

Emerging Microbes & Infections(2024)10.1080/22221751.2024.2432353
N/A
0.251DataRank · unranked
4 citations

Marie Alexandre, Mélanie Prague, Abdoul Habib Béavogui, Seydou Doumbia, Mark Kieh +94 more

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells

PLoS ONE(2021)10.1371/journal.pone.0245024
N/A
0DataRank · unranked
4 citations

Shuǐqìng Yú, Xiǎolì Chī, Sheli R. Radoshitzky, Jens H. Kuhn, Edward A. Berger +1 more

Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.05.434152
N/A
0DataRank · unranked
7 citations

Elena Postnikova, Janie Liang, Robin Gross, Steven Mazur, Saurabh Dixit +9 more

Global remodeling of ADP-ribosylation by PARP1 suppresses influenza A virus infection

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.19.613696
N/A
0DataRank · unranked
4 citations

Isabel Uribe, Kaitlin A. Davis, Robert Lyle McPherson, Gloria P. Larson, Mohsen Badiee +13 more

Reporter Assays for Ebola Virus Nucleoprotein Oligomerization, Virion-Like Particle Budding, and Minigenome Activity Reveal the Importance of Nucleoprotein Amino Acid Position 111

Viruses(2020)10.3390/v12010105
N/A
0DataRank · unranked
13 citations

William E. Diehl, Yíngyún Caì, Courtney L. Finch, Chidiebere Akusobi, Robert N. Kirchdoerfer +9 more

Global remodeling of ADP-ribosylation by PARP1 suppresses influenza A virus infection

Nature Communications(2025)10.1038/s41467-025-66136-6
N/A
0DataRank · unranked
5 citations

Isabel Uribe, Kaitlin A. Davis, Robert Lyle McPherson, Gloria P. Larson, Mohsen Badiee +13 more

Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties

JCI Insight(2021)10.1172/jci.insight.153165
N/A
0DataRank · unranked
20 citations

Elena Postnikova, Brett Eaton, Yíngyún Caì, Shuǐqìng Yú, Charles O. Smith +7 more

Development and Characterization of a cDNA-Launch Recombinant Simian Hemorrhagic Fever Virus Expressing Enhanced Green Fluorescent Protein: ORF 2b’ Is Not Required for In Vitro Virus Replication

Viruses(2021)10.3390/v13040632
N/A
0DataRank · unranked
8 citations

Shuǐqìng Yú, Yīng Fāng, Laura Bollinger, Yànhuá Lǐ, Michael Lauck +12 more